Source - SMW
Oncimmune Holdings announced the signing of two further distribution agreements for its EarlyCDT-Lung test kit in Taiwan and Hong Kong, alongside a business update at the end of its first full financial year.

"It has been a highly productive year and one in which we have made significant progress in delivering on the growth strategy laid out at the time of our IPO," said CEO Geoffrey Hamilton-Fairley. 

"Our recent CE Mark for the EarlyCDT-Lung kit and signing of first distribution agreements in Asia highlight the potential for further expansion into world markets," he said.  

"With progress also made in the US and in the development of our pipeline we look forward with confidence to delivering value in the medium and long term."